text:
DNA methylation
From Wikipedia, the free encyclopedia
Jump to navigation Jump to search
Representation of a DNA molecule that is methylated. The two white spheres represent methyl groups. They are bound to two cytosine nucleotide molecules that make up the DNA sequence.
DNA methylation is a process by which methyl groups are added to the DNA molecule. Methylation can change the activity of a DNA segment without changing the sequence. When located in a gene promoter, DNA methylation typically acts to repress gene transcription. DNA methylation is essential for normal development and is associated with a number of key processes including genomic imprinting, X-chromosome inactivation, repression of transposable elements, aging and carcinogenesis.
Two of DNA's four bases, cytosine and adenine, can be methylated. Cytosine methylation is widespread in both eukaryotes and prokaryotes, even though the rate of cytosine DNA methylation can differ greatly between species: 14% of cytosines are methylated in Arabidopsis thaliana, 8% in Physarum,[1] 4% in Mus musculus, 2.3% in Escherichia coli, 0.03% in Drosophila, 0.006% in Dictyostelium[2] and virtually none (< 0.0002%) in Caenorhabditis[3] or yeast species such as Saccharomyces cerevisiae and S. pombe (but not N. crassa).[4][5] Adenine methylation has been observed in bacterial, plant and recently in mammalian DNA,[6][7] but has received considerably less attention.
Methylation of cytosine to form 5-methylcytosine occurs at the same 5 position on the pyrimidine ring where the DNA base thymine's methyl group is located; the same position distinguishes thymine from the analogous RNA base uracil, which has no methyl group. Spontaneous deamination of 5-methylcytosine converts it to thymine. This results in a T:G mismatch. Repair mechanisms then correct it back to the original C:G pair; alternatively, they may substitute G for A, turning the original C:G pair into an T:A pair, effectively changing a base and introducing a mutation. This misincorporated base will not be corrected during DNA replication as thymine is a DNA base. If the mismatch is not repaired and the cell enters the cell cycle the strand carrying the T will be complemented by an A in one of the daughter cells, such that the mutation becomes permanent. The near-universal replacement of uracil by thymine in DNA, but not RNA, may have evolved as an error-control mechanism, to facilitate the removal of uracils generated by the spontaneous deamination of cytosine.[8] DNA methylation as well as many of its contemporary DNA methyltransferases has been thought to evolve from early world primitive RNA methylation activity and is supported by several lines of evidence.[9]
In plants and other organisms, DNA methylation is found in three different sequence contexts: CG (or CpG), CHG or CHH (where H correspond to A, T or C). In mammals however, DNA methylation is almost exclusively found in CpG dinucleotides, with the cytosines on both strands being usually methylated. Non-CpG methylation can however be observed in embryonic stem cells,[10][11][12] and has also been indicated in neural development.[13] Furthermore, non-CpG methylation has also been observed in hematopoietic progenitor cells, and it occurred mainly in a CpApC sequence context.[14]
Contents
1 Conserved function of DNA methylation
1.1 CpG islands
1.2 Repression of CpG-dense promoters
1.3 Repression of transposable elements
1.4 Methylation of the gene body of highly transcribed genes
2 In mammals
2.1 During embryonic development
2.2 In cancer
2.3 In atherosclerosis
2.4 In aging
2.5 In exercise
2.6 In B-cell differentiation
2.7 In the brain
3 DNA methyltransferases (in mammals)
4 In plants
5 In insects
6 In fungi
7 In lower eukaryotes
8 In bacteria
8.1 Molecular cloning
9 Detection
10 Differentially methylated regions (DMRs)
11 DNA methylation marks
12 Computational prediction
13 See also
14 References
15 Further reading
16 External links
Conserved function of DNA methylation[edit]
Typical DNA methylation landscape in mammals
The DNA methylation landscape of vertebrates is very particular compared to other organisms. In vertebrates, around 60–80% of CpG are methylated in somatic cells[15] and DNA methylation appears as a default state that has to be specifically excluded from defined locations.[16][17] By contrast, the genome of most plants, invertebrates, fungi or protists show “mosaic” methylation patterns, where only specific genomic elements are targeted, and they are characterized by the alternation of methylated and unmethylated domains.[4][18]
High CpG methylation in mammalian genomes has an evolutionary cost because it increases the frequency of spontaneous mutations. Loss of amino-groups occurs with a high frequency for cytosines, with different consequences depending on their methylation. Methylated C residues spontaneously deaminate to form T residues over time; hence CpG dinucleotides steadily deaminate to TpG dinucleotides, which is evidenced by the under-representation of CpG dinucleotides in the human genome (they occur at only 21% of the expected frequency).[19] (On the other hand, spontaneous deamination of unmethylated C residues gives rise to U residues, a change that is quickly recognized and repaired by the cell.)
CpG islands[edit]
In mammals, the only exception for this global CpG depletion resides in a specific category of GC- and CpG-rich sequences termed CpG islands that are generally unmethylated and therefore retained the expected CpG content.[20] CpG islands are usually defined as regions with 1) a length greater than 200bp, 2) a G+C content greater than 50%, 3) a ratio of observed to expected CpG greater than 0.6, although other definitions are sometimes used.[21] Excluding repeated sequences, there are around 25,000 CpG islands in the human genome, 75% of which being less than 850bp long.[22] They are major regulatory units and around 50% of CpG islands are located in gene promoter regions, while another 25% lie in gene bodies, often serving as alternative promoters. Reciprocally, around 60-70% of human genes have a CpG island in their promoter region.[23][24] The majority of CpG islands are constitutively unmethylated and enriched for permissive chromatin modification such as H3K4 methylation. In somatic tissues, only 10% of CpG islands are methylated, the majority of them being located in intergenic and intragenic regions.
Repression of CpG-dense promoters[edit]
DNA methylation was probably present at some extent in very early eukaryote ancestors. In virtually every organism analyzed, methylation in promoter regions correlates negatively with gene expression.[4][25] CpG-dense promoters of actively transcribed genes are never methylated, but reciprocally transcriptionally silent genes do not necessarily carry a methylated promoter. In mouse and human, around 60–70% of genes have a CpG island in their promoter region and most of these CpG islands remain unmethylated independently of the transcriptional activity of the gene, in both differentiated and undifferentiated cell types.[26][27] Of note, whereas DNA methylation of CpG islands is unambiguously linked with transcriptional repression, the function of DNA methylation in CG-poor promoters remains unclear; albeit there is little evidence that it could be functionally relevant.[28]
DNA methylation may affect the transcription of genes in two ways. First, the methylation of DNA itself may physically impede the binding of transcriptional proteins to the gene,[29] and second, and likely more important, methylated DNA may be bound by proteins known as methyl-CpG-binding domain proteins (MBDs). MBD proteins then recruit additional proteins to the locus, such as histone deacetylases and other chromatin remodeling proteins that can modify histones, thereby forming compact, inactive chromatin, termed heterochromatin. This link between DNA methylation and chromatin structure is very important. In particular, loss of methyl-CpG-binding protein 2 (MeCP2) has been implicated in Rett syndrome; and methyl-CpG-binding domain protein 2 (MBD2) mediates the transcriptional silencing of hypermethylated genes in cancer.
Repression of transposable elements[edit]
DNA methylation is a powerful transcriptional repressor, at least in CpG dense contexts. Transcriptional repression of protein-coding genes appears essentially limited to very specific classes of genes that need to be silent permanently and in almost all tissues. While DNA methylation does not have the flexibility required for the fine-tuning of gene regulation, its stability is perfect to ensure the permanent silencing of transposable elements. Transposon control is one the most ancient functions of DNA methylation that is shared by animals, plants and multiple protists.[30] It is even suggested that DNA methylation evolved precisely for this purpose.[31]
Methylation of the gene body of highly transcribed genes[edit]
A function that appears even more conserved than transposon silencing is positively correlated with gene expression. In almost all species where DNA methylation is present, DNA methylation is especially enriched in the body of highly transcribed genes.[4][25] The function of gene body methylation is not well understood. A body of evidence suggests that it could regulate splicing[32] and suppress the activity of intragenic transcriptional units (cryptic promoters or transposable elements).[33] Gene-body methylation appears closely tied to H3K36 methylation. In yeast and mammals, H3K36 methylation is highly enriched in the body of highly transcribed genes. In yeast at least, H3K36me3 recruits enzymes such as histone deacetylases to condense chromatin and prevent the activation of cryptic start sites.[34] In mammals, DNMT3a and DNMT3b PWWP domain binds to H3K36me3 and the two enzymes are recruited to the body of actively transcribed genes.
In mammals[edit]
Dynamic of DNA methylation during mouse embryonic development. E3.5-E6, etc., refer to days after fertilization. PGC: primordial germ cells
During embryonic development[edit]
Main article: DNA methylation reprogramming
DNA methylation patterns are largely erased and then re-established between generations in mammals. Almost all of the methylations from the parents are erased, first during gametogenesis, and again in early embryogenesis, with demethylation and remethylation occurring each time. Demethylation in early embryogenesis occurs in the preimplantation period in two stages – initially in the zygote, then during the first few embryonic replication cycles of morula and blastula. A wave of methylation then takes place during the implantation stage of the embryo, with CpG islands protected from methylation. This results in global repression and allows housekeeping genes to be expressed in all cells. In the post-implantation stage, methylation patterns are stage- and tissue-specific, with changes that would define each individual cell type lasting stably over a long period.[35]
Whereas DNA methylation is not necessary per se for transcriptional silencing, it is thought nonetheless to represent a “locked” state that definitely inactivates transcription. In particular, DNA methylation appears critical for the maintenance of mono-allelic silencing in the context of genomic imprinting and X chromosome inactivation.[36][37] In these cases, expressed and silent alleles differ by their methylation status, and loss of DNA methylation results in loss of imprinting and re-expression of Xist in somatic cells. During embryonic development, few genes change their methylation status, at the important exception of many genes specifically expressed in the germline.[38] DNA methylation appears absolutely required in differentiated cells, as knockout of any of the three competent DNA methyltransferase results in embryonic or post-partum lethality. By contrast, DNA methylation is dispensable in undifferentiated cell types, such as the inner cell mass of the blastocyst, primordial germ cells or embryonic stem cells. Since DNA methylation appears to directly regulate only a limited number of genes, how precisely DNA methylation absence causes the death of differentiated cells remain an open question.
Due to the phenomenon of genomic imprinting, maternal and paternal genomes are differentially marked and must be properly reprogrammed every time they pass through the germline. Therefore, during gametogenesis, primordial germ cells must have their original biparental DNA methylation patterns erased and re-established based on the sex of the transmitting parent. After fertilization the paternal and maternal genomes are once again demethylated and remethylated (except for differentially methylated regions associated with imprinted genes). This reprogramming is likely required for totipotency of the newly formed embryo and erasure of acquired epigenetic changes.[39]
In cancer[edit]
Main articles: DNA methylation in cancer and Regulation of transcription in cancer
In many disease processes, such as cancer, gene promoter CpG islands acquire abnormal hypermethylation, which results in transcriptional silencing that can be inherited by daughter cells following cell division.[40] Alterations of DNA methylation have been recognized as an important component of cancer development. Hypomethylation, in general, arises earlier and is linked to chromosomal instability and loss of imprinting, whereas hypermethylation is associated with promoters and can arise secondary to gene (oncogene suppressor) silencing, but might be a target for epigenetic therapy.[41]
Global hypomethylation has also been implicated in the development and progression of cancer through different mechanisms.[42] Typically, there is hypermethylation of tumor suppressor genes and hypomethylation of oncogenes.[43]
Generally, in progression to cancer, hundreds of genes are silenced or activated. Although silencing of some genes in cancers occurs by mutation, a large proportion of carcinogenic gene silencing is a result of altered DNA methylation (see DNA methylation in cancer). DNA methylation causing silencing in cancer typically occurs at multiple CpG sites in the CpG islands that are present in the promoters of protein coding genes.
Altered expressions of microRNAs also silence or activate many genes in progression to cancer (see microRNAs in cancer). Altered microRNA expression occurs through hyper/hypo-methylation of CpG sites in CpG islands in promoters controlling transcription of the microRNAs.
Silencing of DNA repair genes through methylation of CpG islands in their promoters appears to be especially important in progression to cancer (see methylation of DNA repair genes in cancer).
In atherosclerosis[edit]
Epigenetic modifications such as DNA methylation have been implicated in cardiovascular disease, including atherosclerosis. In animal models of atherosclerosis, vascular tissue as well as blood cells such as mononuclear blood cells exhibit global hypomethylation with gene-specific areas of hypermethylation. DNA methylation polymorphisms may be used as an early biomarker of atherosclerosis since they are present before lesions are observed, which may provide an early tool for detection and risk prevention.[44]
Two of the cell types targeted for DNA methylation polymorphisms are monocytes and lymphocytes, which experience an overall hypomethylation. One proposed mechanism behind this global hypomethylation is elevated homocysteine levels causing hyperhomocysteinemia, a known risk factor for cardiovascular disease. High plasma levels of homocysteine inhibit DNA methyltransferases, which causes hypomethylation. Hypomethylation of DNA affects gene that alter smooth muscle cell proliferation, cause endothelial cell dysfunction, and increase inflammatory mediators, all of which are critical in forming atherosclerotic lesions.[45] High levels of homocysteine also result in hypermethylation of CpG islands in the promoter region of the estrogen receptor alpha (ERα) gene, causing its down regulation.[46] ERα protects against atherosclerosis due to its action as a growth suppressor, causing the smooth muscle cells to remain in a quiescent state.[47] Hypermethylation of the ERα promoter thus allows intimal smooth muscle cells to proliferate excessively and contribute to the development of the atherosclerotic lesion.[48]
Another gene that experiences a change in methylation status in atherosclerosis is the monocarboxylate transporter (MCT3), which produces a protein responsible for the transport of lactate and other ketone bodies out of many cell types, including vascular smooth muscle cells. In atherosclerosis patients, there is an increase in methylation of the CpG islands in exon 2, which decreases MCT3 protein expression. The down regulation of MCT3 impairs lactate transport, and significantly increases smooth muscle cell proliferation, which further contributes to the atherosclerotic lesion. An ex vivo experiment using the demethylating agent Decitabine (5-aza-2 -deoxycytidine) was shown to induce MCT3 expression in a dose dependant manner, as all hypermethylated sites in the exon 2 CpG island became demethylated after treatment. This may serve as a novel therapeutic agent to treat atherosclerosis, although no human studies have been conducted thus far.[49]
In aging[edit]
In humans and other mammals, DNA methylation levels can be used to accurately estimate the age of tissues and cell types, forming an accurate epigenetic clock.[50]
A longitudinal study of twin children showed that, between the ages of 5 and 10, there was divergence of methylation patterns due to environmental rather than genetic influences.[51] There is a global loss of DNA methylation during aging.[43]
In a study that analyzed the complete DNA methylomes of CD4+ T cells in a newborn, a 26 years old individual and a 103 years old individual was observed that the loss of methylation is proportional to age. Hypomethylated CpGs observed in the centenarian DNAs compared with the neonates covered all genomic compartments (promoters, intergenic, intronic and exonic regions).[52] However, some genes become hypermethylated with age, including genes for the estrogen receptor, p16, and insulin-like growth factor 2.[43]
In exercise[edit]
High intensity exercise has been shown to result in reduced DNA methylation in skeletal muscle.[53] Promoter methylation of PGC-1α and PDK4 were immediately reduced after high intensity exercise, whereas PPAR-γ methylation was not reduced until three hours after exercise.[53] By contrast, six months of exercise in previously sedentary middle-age men resulted in increased methylation in adipose tissue.[54] One study showed a possible increase in global genomic DNA methylation of white blood cells with more physical activity in non-Hispanics.[55]
In B-cell differentiation[edit]
A study that investigated the methylome of B cells along their differentiation cycle, using whole-genome bisulfite sequencing (WGBS), showed that there is a hypomethylation from the earliest stages to the most differentiated stages. The largest methylation difference is between the stages of germinal center B cells and memory B cells. Furthermore, this study showed that there is a similarity between B cell tumors and long-lived B cells in their DNA methylation signatures.[14]
In the brain[edit]
Research has suggested that long-term memory storage in humans may be regulated by DNA methylation.[56][57]
DNA methyltransferases (in mammals)[edit]
Possible pathways of cytosine methylation and demethylation. Abbreviations: S-Adenosyl-L-homocysteine (SAH), S-adenosyl-L-methionine (SAM), DNA methyltransferase (DNA MTase), Uracil-DNA glycosylase (UNG)
In mammalian cells, DNA methylation occurs mainly at the C5 position of CpG dinucleotides and is carried out by two general classes of enzymatic activities – maintenance methylation and de novo methylation.[58]
Maintenance methylation activity is necessary to preserve DNA methylation after every cellular DNA replication cycle. Without the DNA methyltransferase (DNMT), the replication machinery itself would produce daughter strands that are unmethylated and, over time, would lead to passive demethylation. DNMT1 is the proposed maintenance methyltransferase that is responsible for copying DNA methylation patterns to the daughter strands during DNA replication. Mouse models with both copies of DNMT1 deleted are embryonic lethal at approximately day 9, due to the requirement of DNMT1 activity for development in mammalian cells.
It is thought that DNMT3a and DNMT3b are the de novo methyltransferases that set up DNA methylation patterns early in development. DNMT3L is a protein that is homologous to the other DNMT3s but has no catalytic activity. Instead, DNMT3L assists the de novo methyltransferases by increasing their ability to bind to DNA and stimulating their activity. Finally, DNMT2 (TRDMT1) has been identified as a DNA methyltransferase homolog, containing all 10 sequence motifs common to all DNA methyltransferases; however, DNMT2 (TRDMT1) does not methylate DNA but instead methylates cytosine-38 in the anticodon loop of aspartic acid transfer RNA.[59]
Since many tumor suppressor genes are silenced by DNA methylation during carcinogenesis, there have been attempts to re-express these genes by inhibiting the DNMTs. 5-Aza-2'-deoxycytidine (decitabine) is a nucleoside analog that inhibits DNMTs by trapping them in a covalent complex on DNA by preventing the β-elimination step of catalysis, thus resulting in the enzymes' degradation. However, for decitabine to be active, it must be incorporated into the genome of the cell, which can cause mutations in the daughter cells if the cell does not die. In addition, decitabine is toxic to the bone marrow, which limits the size of its therapeutic window. These pitfalls have led to the development of antisense RNA therapies that target the DNMTs by degrading their mRNAs and preventing their translation. However, it is currently unclear whether targeting DNMT1 alone is sufficient to reactivate tumor suppressor genes silenced by DNA methylation.
In plants[edit]
Significant progress has been made in understanding DNA methylation in the model plant Arabidopsis thaliana. DNA methylation in plants differs from that of mammals: while DNA methylation in mammals mainly occurs on the cytosine nucleotide in a CpG site, in plants the cytosine can be methylated at CpG, CpHpG, and CpHpH sites, where H represents any nucleotide but not guanine. Overall, Arabidopsis DNA is highly methylated, mass spectrometry analysis estimated 14% of cytosines to be modified.[5]
The principal Arabidopsis DNA methyltransferase enzymes, which transfer and covalently attach methyl groups onto DNA, are DRM2, MET1, and CMT3. Both the DRM2 and MET1 proteins share significant homology to the mammalian methyltransferases DNMT3 and DNMT1, respectively, whereas the CMT3 protein is unique to the plant kingdom. There are currently two classes of DNA methyltransferases: 1) the de novo class, or enzymes that create new methylation marks on the DNA; and 2) a maintenance class that recognizes the methylation marks on the parental strand of DNA and transfers new methylation to the daughters strands after DNA replication. DRM2 is the only enzyme that has been implicated as a de novo DNA methyltransferase. DRM2 has also been shown, along with MET1 and CMT3 to be involved in maintaining methylation marks through DNA replication.[60] Other DNA methyltransferases are expressed in plants but have no known function (see the Chromatin Database).
It is not clear how the cell determines the locations of de novo DNA methylation, but evidence suggests that, for many (though not all) locations, RNA-directed DNA methylation (RdDM) is involved. In RdDM, specific RNA transcripts are produced from a genomic DNA template, and this RNA forms secondary structures called double-stranded RNA molecules.[61] The double-stranded RNAs, through either the small interfering RNA (siRNA) or microRNA (miRNA) pathways direct de-novo DNA methylation of the original genomic location that produced the RNA.[61] This sort of mechanism is thought to be important in cellular defense against RNA viruses and/or transposons, both of which often form a double-stranded RNA that can be mutagenic to the host genome. By methylating their genomic locations, through an as yet poorly understood mechanism, they are shut off and are no longer active in the cell, protecting the genome from their mutagenic effect. Recently, it was described that methylation of the DNA is the main determinant of embryogenic cultures formation from explants in woody plants and is regarded the main mechanism that explains the poor response of mature explants to somatic embryogenesis in the plants (Isah 2016).
In insects[edit]
Further information: Epigenetics in insects
Functional DNA methylation has been discovered in Honey Bees.[62][63] DNA methylation marks are mainly on the gene body, and current opinions on the function of DNA methylation is gene regulation via alternative splicing [64]
DNA methylation levels in Drosophila melanogaster are nearly undetectable.[65] Sensitive methods applied to Drosophila DNA Suggest levels in the range of 0.1–0.3% of total cytosine.[66] This low level of methylation [67] appears to reside in genomic sequence patterns that are very different from patterns seen in humans, or in other animal or plant species to date. Genomic methylation in D. melanogaster was found at specific short motifs (concentrated in specific 5-base sequence motifs that are CA- and CT-rich but depleted of guanine) and is independent of DNMT2 activity. Further, highly sensitive mass spectrometry approaches,[68] have now demonstrated the presence of low (0.07%) but significant levels of adenine methylation during the earliest stages of Drosophila embryogenesis.
In fungi[edit]
Many fungi have low levels (0.1 to 0.5%) of cytosine methylation, whereas other fungi have as much as 5% of the genome methylated.[69] This value seems to vary both among species and among isolates of the same species.[70] There is also evidence that DNA methylation may be involved in state-specific control of gene expression in fungi.[citation needed] However, at a detection limit of 250 attomoles by using ultra-high sensitive mass spectrometry DNA methylation was not confirmed in single cellular yeast species such as Saccharomyces cerevisiae or Schizosaccharomyces pombe, indicating that yeasts do not possess this DNA modification.[5]
Although brewers' yeast (Saccharomyces), fission yeast (Schizosaccharomyces), and Aspergillus flavus[71] have no detectable DNA methylation, the model filamentous fungus Neurospora crassa has a well-characterized methylation system.[72] Several genes control methylation in Neurospora and mutation of the DNA methyl transferase, dim-2, eliminates all DNA methylation but does not affect growth or sexual reproduction. While the Neurospora genome has very little repeated DNA, half of the methylation occurs in repeated DNA including transposon relics and centromeric DNA. The ability to evaluate other important phenomena in a DNA methylase-deficient genetic background makes Neurospora an important system in which to study DNA methylation.
In lower eukaryotes[edit]
DNA methylation is largely absent from Dictyostelium discoidium[73] where it appears to occur at about 0.006% of cytosines.[2] In contrast, DNA methylation is widely distributed in Physarum polycephalum [74] where 5-methylcytosine makes up as much as 8% of total cytosine[1]
In bacteria[edit]
Adenine or cytosine methylation is part of the restriction modification system of many bacteria, in which specific DNA sequences are methylated periodically throughout the genome. A methylase is the enzyme that recognizes a specific sequence and methylates one of the bases in or near that sequence. Foreign DNAs (which are not methylated in this manner) that are introduced into the cell are degraded by sequence-specific restriction enzymes and cleaved. Bacterial genomic DNA is not recognized by these restriction enzymes. The methylation of native DNA acts as a sort of primitive immune system, allowing the bacteria to protect themselves from infection by bacteriophage.
E. coli DNA adenine methyltransferase (Dam) is an enzyme of ~32 kDa that does not belong to a restriction/modification system. The target recognition sequence for E. coli Dam is GATC, as the methylation occurs at the N6 position of the adenine in this sequence (G meATC). The three base pairs flanking each side of this site also influence DNA–Dam binding. Dam plays several key roles in bacterial processes, including mismatch repair, the timing of DNA replication, and gene expression. As a result of DNA replication, the status of GATC sites in the E. coli genome changes from fully methylated to hemimethylated. This is because adenine introduced into the new DNA strand is unmethylated. Re-methylation occurs within two to four seconds, during which time replication errors in the new strand are repaired. Methylation, or its absence, is the marker that allows the repair apparatus of the cell to differentiate between the template and nascent strands. It has been shown that altering Dam activity in bacteria results in increased spontaneous mutation rate. Bacterial viability is compromised in dam mutants that also lack certain other DNA repair enzymes, providing further evidence for the role of Dam in DNA repair.
One region of the DNA that keeps its hemimethylated status for longer is the origin of replication, which has an abundance of GATC sites. This is central to the bacterial mechanism for timing DNA replication. SeqA binds to the origin of replication, sequestering it and thus preventing methylation. Because hemimethylated origins of replication are inactive, this mechanism limits DNA replication to once per cell cycle.
Expression of certain genes, for example those coding for pilus expression in E. coli, is regulated by the methylation of GATC sites in the promoter region of the gene operon. The cells' environmental conditions just after DNA replication determine whether Dam is blocked from methylating a region proximal to or distal from the promoter region. Once the pattern of methylation has been created, the pilus gene transcription is locked in the on or off position until the DNA is again replicated. In E. coli, these pilus operons have important roles in virulence in urinary tract infections. It has been proposed[by whom?] that inhibitors of Dam may function as antibiotics.
On the other hand, DNA cytosine methylase targets CCAGG and CCTGG sites to methylate cytosine at the C5 position (C meC(A/T) GG). The other methylase enzyme, EcoKI, causes methylation of adenines in the sequences AAC(N6)GTGC and GCAC(N6)GTT.
Molecular cloning[edit]
Most strains used by molecular biologists are derivatives of E. coli K-12, and possess both Dam and Dcm, but there are commercially available strains that are dam-/dcm- (lack of activity of either methylase). In fact, it is possible to unmethylate the DNA extracted from dam+/dcm+ strains by transforming it into dam-/dcm- strains. This would help digest sequences that are not being recognized by methylation-sensitive restriction enzymes.[75][76]
The restriction enzyme DpnI can recognize 5'-GmeATC-3' sites and digest the methylated DNA. Being such a short motif, it occurs frequently in sequences by chance, and as such its primary use for researchers is to degrade template DNA following PCRs (PCR products lack methylation, as no methylases are present in the reaction). Similarly, some commercially available restriction enzymes are sensitive to methylation at their cognate restriction sites, and must as mentioned previously be used on DNA passed through a dam-/dcm- strain to allow cutting.
Detection[edit]
DNA methylation can be detected by the following assays currently used in scientific research:[77]
Mass spectrometry is a very sensitive and reliable analytical method to detect DNA methylation. MS in general is however not informative about the sequence context of the methylation, thus limited in studying the function of this DNA modification.
Methylation-Specific PCR (MSP), which is based on a chemical reaction of sodium bisulfite with DNA that converts unmethylated cytosines of CpG dinucleotides to uracil or UpG, followed by traditional PCR.[78] However, methylated cytosines will not be converted in this process, and primers are designed to overlap the CpG site of interest, which allows one to determine methylation status as methylated or unmethylated.
Whole genome bisulfite sequencing, also known as BS-Seq, which is a high-throughput genome-wide analysis of DNA methylation. It is based on aforementioned sodium bisulfite conversion of genomic DNA, which is then sequenced on a Next-generation sequencing platform. The sequences obtained are then re-aligned to the reference genome to determine methylation states of CpG dinucleotides based on mismatches resulting from the conversion of unmethylated cytosines into uracil.
Reduced representation bisulfite sequencing, also known as RRBS knows several working protocols. The first RRBS protocol was called RRBS and aims for around 10% of the methylome, a reference genome is needed. Later came more protocols that were able to sequence a smaller portion of the genome and higher sample multiplexing. EpiGBS was the first protocol were you could multiplex 96 sample in one lane of Illumina sequencing and were a reference genome was not longer needed. A de novo reference construction from the Watson and Crick reads made population screening of SNP's and SMP's simultaneously a fact.
The HELP assay, which is based on restriction enzymes' differential ability to recognize and cleave methylated and unmethylated CpG DNA sites.
GLAD-PCR assay, which is based on new type of enzymes – site-specific methyl-directed DNA endonucleases, which hydrolyze only methylated DNA.
ChIP-on-chip assays, which is based on the ability of commercially prepared antibodies to bind to DNA methylation-associated proteins like MeCP2.
Restriction landmark genomic scanning, a complicated and now rarely used assay based upon restriction enzymes' differential recognition of methylated and unmethylated CpG sites; the assay is similar in concept to the HELP assay.
Methylated DNA immunoprecipitation (MeDIP), analogous to chromatin immunoprecipitation, immunoprecipitation is used to isolate methylated DNA fragments for input into DNA detection methods such as DNA microarrays (MeDIP-chip) or DNA sequencing (MeDIP-seq).
Pyrosequencing of bisulfite treated DNA. This is sequencing of an amplicon made by a normal forward primer but a biotinylated reverse primer to PCR the gene of choice. The Pyrosequencer then analyses the sample by denaturing the DNA and adding one nucleotide at a time to the mix according to a sequence given by the user. If there is a mis-match, it is recorded and the percentage of DNA for which the mis-match is present is noted. This gives the user a percentage methylation per CpG island.
Molecular break light assay for DNA adenine methyltransferase activity – an assay that relies on the specificity of the restriction enzyme DpnI for fully methylated (adenine methylation) GATC sites in an oligonucleotide labeled with a fluorophore and quencher. The adenine methyltransferase methylates the oligonucleotide making it a substrate for DpnI. Cutting of the oligonucleotide by DpnI gives rise to a fluorescence increase.[79][80]
Methyl Sensitive Southern Blotting is similar to the HELP assay, although uses Southern blotting techniques to probe gene-specific differences in methylation using restriction digests. This technique is used to evaluate local methylation near the binding site for the probe.
MethylCpG Binding Proteins (MBPs) and fusion proteins containing just the Methyl Binding Domain (MBD) are used to separate native DNA into methylated and unmethylated fractions. The percentage methylation of individual CpG islands can be determined by quantifying the amount of the target in each fraction.[81] Extremely sensitive detection can be achieved in FFPE tissues with abscription-based detection.
High Resolution Melt Analysis (HRM or HRMA), is a post-PCR analytical technique. The target DNA is treated with sodium bisulfite, which chemically converts unmethylated cytosines into uracils, while methylated cytosines are preserved. PCR amplification is then carried out with primers designed to amplify both methylated and unmethylated templates. After this amplification, highly methylated DNA sequences contain a higher number of CpG sites compared to unmethylated templates, which results in a different melting temperature that can be used in quantitative methylation detection.[82][83]
Ancient DNA methylation reconstruction, a method to reconstruct high-resolution DNA methylation from ancient DNA samples. The method is based on the natural degradation processes that occur in ancient DNA: with time, methylated cytosines are degraded into thymines, whereas unmethylated cytosines are degraded into uracils. This asymmetry in degradation signals was used to reconstruct the full methylation maps of the Neanderthal and the Denisovan [84]
Differentially methylated regions (DMRs)[edit]
Differentially methylated regions, are genomic regions with different methylation statuses among multiple samples (tissues, cells, individuals or others), are regarded as possible functional regions involved in gene transcriptional regulation. The identification of DMRs among multiple tissues (T-DMRs) provides a comprehensive survey of epigenetic differences among human tissues.[85] For example, these methylated regions that are unique to a particular tissue allow individuals to differentiate between tissue type, such as semen and vaginal fluid. Current research conducted by Lee et al., showed DACT1 and USP49 positively identified semen by examining T-DMRs.[86] DMRs between cancer and normal samples (C-DMRs) demonstrate the aberrant methylation in cancers.[87] It is well known that DNA methylation is associated with cell differentiation and proliferation.[88] Many DMRs have been found in the development stages (D-DMRs) [89] and in the reprogrammed progress (R-DMRs).[90] In addition, there are intra-individual DMRs (Intra-DMRs) with longitudinal changes in global DNA methylation along with the increase of age in a given individual.[91] There are also inter-individual DMRs (Inter-DMRs) with different methylation patterns among multiple individuals.[92]
QDMR (Quantitative Differentially Methylated Regions) is a quantitative approach to quantify methylation difference and identify DMRs from genome-wide methylation profiles by adapting Shannon entropy <http://bioinfo.hrbmu.edu.cn/qdmr>. The platform-free and species-free nature of QDMR makes it potentially applicable to various methylation data. This approach provides an effective tool for the high-throughput identification of the functional regions involved in epigenetic regulation. QDMR can be used as an effective tool for the quantification of methylation difference and identification of DMRs across multiple samples.[93]
Gene-set analysis (a.k.a. pathway analysis; usually performed tools such as DAVID, GoSeq or GSEA) has been shown to be severely biased when applied to high-throughput methylation data (e.g. MeDIP-seq, MeDIP-ChIP, HELP-seq etc.), and a wide range of studies have thus mistakenly reported hyper-methylation of genes related to development and differentiation; it has been suggested that this can be corrected using sample label permutations or using a statistical model to control for differences in the numberes of CpG probes / CpG sites that target each gene.[94]
DNA methylation marks[edit]
DNA methylation marks, are genomic regions with specific methylation pattern in a specific biological state such as tissue, cell type, individual), are regarded as possible functional regions involved in gene transcriptional regulation. Although various human cell types may have the same genome, these cells have different methylomes. The systematic identification and characterization of methylation marks across cell types are crucial to understanding the complex regulatory network for cell fate determination. Hongbo Liu et al. proposed an entropy-based framework termed SMART to integrate the whole genome bisulfite sequencing methylomes across 42 human tissues/cells and identified 757,887 genome segments.[95] Nearly 75% of the segments showed uniform methylation across all cell types. From the remaining 25% of the segments, they identified cell type-specific hypo/hypermethylation marks that were specifically hypo/hypermethylated in a minority of cell types using a statistical approach and presented an atlas of the human methylation marks. Further analysis revealed that the cell type-specific hypomethylation marks were enriched through H3K27ac and transcription factor binding sites in cell type-specific manner. In particular, they observed that the cell type-specific hypomethylation marks are associated with the cell type-specific super-enhancers that drive the expression of cell identity genes. This framework provides a complementary, functional annotation of the human genome and helps to elucidate the critical features and functions of cell type-specific hypomethylation.
The entropy-based Specific Methylation Analysis and Report Tool, termed "SMART", which focuses on integrating a large number of DNA methylomes for the de novo identification of cell type-specific methylation marks. The latest version of SMART is focused on three main functions including de novo identification of differentially methylated regions (DMRs) by genome segmentation, identification of DMRs from predefined regions of interest, and identification of differentially methylated CpG sites. SMART is available at http://fame.edbc.org/smart/.
Computational prediction[edit]
DNA methylation can also be detected by computational models through sophisticated algorithms and methods. Computational models can facilitate the global profiling of DNA methylation across chromosomes, and often such models are faster and cheaper to perform than biological assays. Such up-to-date computational models include Bhasin, et al.,[96] Bock, et al.,[97] and Zheng, et al.[98] [99] Together with biological assay, these methods greatly facilitate the DNA methylation analysis.
See also[edit]
5-Hydroxymethylcytosine
5-Methylcytosine
7-Methylguanosine
Demethylating agent
Differentially methylated regions
DNA demethylation
DNA methylation age
DNA methylation reprogramming
Epigenetics, of which DNA methylation is a significant contributor
Epigenome
Genome
Genomic imprinting, an inherited repression of an allele, relying on DNA methylation
MethBase DNA Methylation database hosted on the UCSC Genome Browser
MethDB DNA Methylation database
N6-Methyladenosine
References[edit]
^ Jump up to: a b Evans, JH, Evans, TE (1970). "Methylation of the deoxyribonucleic acid of Physarum polycephalum at various periods during the mitotic cycle". Journal of Biological Chemistry. 245 (23): 6436–6441. PMID 5530731.
^ Jump up to: a b Steenwyk, JL, St-Denis, J, Dresch, J, Larochelle, D, Drewell, RA (2017). "Whole genome bisulfite sequencing reveals a sparse, but robust pattern of DNA methylation in the Dictyostelium discoideum genome". bioRxiv 166033  .
Jump up ^ Hu, CW, Chen, JL, Hsu, YW, Yen, CC, Chao, MR (2015). "Trace analysis of methylated and hydroxymethylated cytosines in DNA by isotope-dilution LC-MS/MS: first evidence of DNA methylation in Caenorhabditis elegans". Biochemical Journal. 465 (1): 39–47. doi:10.1042/bj20140844. PMID 25299492.
^ Jump up to: a b c d Zemach, Assaf; McDaniel, Ivy E.; Silva, Pedro; Zilberman, Daniel (2010-05-14). "Genome-Wide Evolutionary Analysis of Eukaryotic DNA Methylation". Science. 328 (5980): 916–919. doi:10.1126/science.1186366. ISSN 0036-8075. PMID 20395474.
^ Jump up to: a b c Capuano, F.; Mülleder, M.; Kok, R. M.; Blom, H. J.; Ralser, M. (2014). "Cytosine DNA methylation is found in Drosophila melanogaster but absent in Saccharomyces cerevisiae, Schizosaccharomyces pombe and other yeast species". Analytical Chemistry. 86 (8): 3697–702. doi:10.1021/ac500447w. PMC 4006885  . PMID 24640988.
Jump up ^ Ratel, David (March 2006). "N6-methyladenine: the other methylated base of DNA". BioEssays. 28 (3): 309–15. doi:10.1002/bies.20342. PMC 2754416  . PMID 16479578.
Jump up ^ Wu, Tao P.; Wang, Tao; Seetin, Matthew G.; Lai, Yongquan; Zhu, Shijia; Lin, Kaixuan; Liu, Yifei; Byrum, Stephanie D.; Mackintosh, Samuel G. (2016-04-21). "DNA methylation on N6-adenine in mammalian embryonic stem cells". Nature. 532 (7599): 329–333. doi:10.1038/nature17640. ISSN 0028-0836. PMC 4977844  . PMID 27027282.
Jump up ^ Angéla Békési and Beáta G Vértessy "Uracil in DNA: error or signal?"
Jump up ^ Rana, Ajay K.; Ankri, Serge (2016). "Reviving the RNA World: An Insight into the Appearance of RNA Methyltransferases". Front Genet. 7: 99. doi:10.3389/fgene.2016.00099. PMC 4893491  . PMID 27375676.
Jump up ^ Dodge, J.E.; Ramsahoye, B.H.; Wo, Z.G.; Okano, M.; Li, E. (2002). "De novo methylation of MMLV provirus in embryonic stem cells: CpG versus non-CpG methylation". Gene. 289 (1–2): 41–48. doi:10.1016/S0378-1119(02)00469-9. CS1 maint: Uses authors parameter (link)
Jump up ^ Haines, T.R.; Rodenhiser, D.I.; Ainsworth, P.J. (2001). "Allele-Specific Non-CpG Methylation of the Nf1 Gene during Early Mouse Development". Developmental Biology. 240 (2): 585–598. doi:10.1006/dbio.2001.0504. PMID 11784085. CS1 maint: Uses authors parameter (link)
Jump up ^ Lister, R., Pelizzola, M.; Dowen, R.H. et al. (October 2009). "Human DNA methylomes at base resolution show widespread epigenomic differences". Nature. 462 (7271): 315–22. doi:10.1038/nature08514. PMC 2857523  . PMID 19829295. CS1 maint: Uses authors parameter (link)
Jump up ^ Lister, R.; Mukamel, E. A.; Nery, J. R.; Urich, M.; Puddifoot, C. A.; Johnson, N. D.; Lucero, J.; Huang, Y.; Dwork, A. J.; Schultz, M. D.; Yu, M.; Tonti-Filippini, J.; Heyn, H.; Hu, S.; Wu, J. C.; Rao, A.; Esteller, M.; He, C.; Haghighi, F. G.; Sejnowski, T. J.; Behrens, M. M.; Ecker, J. R. (4 July 2013). "Global Epigenomic Reconfiguration During Mammalian Brain Development". Science. 341 (6146): 1237905. doi:10.1126/science.1237905. PMC 3785061  . PMID 23828890.
^ Jump up to: a b Kulis, Marta; Merkel, Angelika; Heath, Simon; Queirós, Ana C.; Schuyler, Ronald P.; Castellano, Giancarlo; Beekman, Renée; Raineri, Emanuele; Esteve, Anna (2015-07-01). "Whole-genome fingerprint of the DNA methylome during human B cell differentiation". Nature Genetics. 47 (7): 746–756. doi:10.1038/ng.3291. ISSN 1061-4036. PMID 26053498.
Jump up ^ Ehrlich M; Gama Sosa MA; Huang L-H.; Midgett RM; Kuo KC; McCune RA; Gehrke C (April 1982). "Amount and distribution of 5-methylcytosine in human DNA from different types of tissues or cells". Nucleic Acids Research. 10 (8): 2709–2721. doi:10.1093/nar/10.8.2709. PMC 320645  . PMID 7079182.
Jump up ^ Lister, Ryan; Pelizzola, Mattia; Dowen, Robert H.; Hawkins, R. David; Hon, Gary; Tonti-Filippini, Julian; Nery, Joseph R.; Lee, Leonard; Ye, Zhen (2009). "Human DNA methylomes at base resolution show widespread epigenomic differences". Nature. 462 (7271): 315–322. doi:10.1038/nature08514. PMC 2857523  . PMID 19829295.
Jump up ^ Stadler, Michael B.; Murr, Rabih; Burger, Lukas; Ivanek, Robert; Lienert, Florian; Schöler, Anne; van Nimwegen, Erik; Wirbelauer, Christiane; Oakeley, Edward J. (2012-04-26). "Corrigendum: DNA-binding factors shape the mouse methylome at distal regulatory regions". Nature. 484 (7395): 550–550. doi:10.1038/nature11086. ISSN 0028-0836.
Jump up ^ Suzuki, Miho M.; Kerr, Alastair R. W.; Sousa, Dina De; Bird, Adrian (2007-05-01). "CpG methylation is targeted to transcription units in an invertebrate genome". Genome Research. 17 (5): 625–631. doi:10.1101/gr.6163007. ISSN 1088-9051. PMC 1855171  . PMID 17420183.
Jump up ^ International Human Genome Sequencing Consortium; et al. (February 2001). "Initial sequencing and analysis of the human genome". Nature. 409 (6822): 860–921. doi:10.1038/35057062. PMID 11237011.
Jump up ^ Bird, Adrian P. (1986-05-15). "CpG-rich islands and the function of DNA methylation". Nature. 321 (6067): 209–213. doi:10.1038/321209a0. PMID 2423876.
Jump up ^ Gardiner-Garden, M.; Frommer, M. (1987-07-20). "CpG Islands in vertebrate genomes". Journal of Molecular Biology. 196 (2): 261–282. doi:10.1016/0022-2836(87)90689-9. PMID 3656447.
Jump up ^ Lander, Eric S.; Linton, Lauren M.; Birren, Bruce; Nusbaum, Chad; Zody, Michael C.; Baldwin, Jennifer; Devon, Keri; Dewar, Ken; Doyle, Michael (2001-02-15). "Initial sequencing and analysis of the human genome". Nature. 409 (6822): 860–921. doi:10.1038/35057062. ISSN 0028-0836. PMID 11237011.
Jump up ^ Illingworth, Robert S.; Gruenewald-Schneider, Ulrike; Webb, Shaun; Kerr, Alastair R. W.; James, Keith D.; Turner, Daniel J.; Smith, Colin; Harrison, David J.; Andrews, Robert (2010-09-23). "Orphan CpG Islands Identify Numerous Conserved Promoters in the Mammalian Genome". PLOS Genetics. 6 (9): e1001134. doi:10.1371/journal.pgen.1001134. ISSN 1553-7404. PMC 2944787  . PMID 20885785.
Jump up ^ Saxonov, Serge; Berg, Paul; Brutlag, Douglas L. (2006-01-31). "A genome-wide analysis of CpG dinucleotides in the human genome distinguishes two distinct classes of promoters". Proceedings of the National Academy of Sciences. 103 (5): 1412–1417. doi:10.1073/pnas.0510310103. ISSN 0027-8424. PMC 1345710  . PMID 16432200.
^ Jump up to: a b Feng, Suhua; Cokus, Shawn J.; Zhang, Xiaoyu; Chen, Pao-Yang; Bostick, Magnolia; Goll, Mary G.; Hetzel, Jonathan; Jain, Jayati; Strauss, Steven H. (2010-05-11). "Conservation and divergence of methylation patterning in plants and animals". Proceedings of the National Academy of Sciences. 107 (19): 8689–8694. doi:10.1073/pnas.1002720107. ISSN 0027-8424. PMC 2889301  . PMID 20395551.
Jump up ^ Mohn, Fabio; Weber, Michael; Rebhan, Michael; Roloff, Tim C.; Richter, Jens; Stadler, Michael B.; Bibel, Miriam; Schübeler, Dirk (2008). "Lineage-Specific Polycomb Targets and De Novo DNA Methylation Define Restriction and Potential of Neuronal Progenitors". Molecular Cell. 30 (6): 755–766. doi:10.1016/j.molcel.2008.05.007.
Jump up ^ Weber, Michael; Hellmann, Ines; Stadler, Michael B; Ramos, Liliana; Pääbo, Svante; Rebhan, Michael; Schübeler, Dirk (2007). "Distribution, silencing potential and evolutionary impact of promoter DNA methylation in the human genome". Nature Genetics. 39 (4): 457–466. doi:10.1038/ng1990.
Jump up ^ Schübeler, Dirk (2015). "Function and information content of DNA methylation". Nature. 517 (7534): 321–326. doi:10.1038/nature14192.
Jump up ^ Choy MK, Movassagh M, Goh HG, Bennett M, Down T, Foo R (2010). "Genome-wide conserved consensus transcription factor binding motifs are hyper-methylated". BMC Genomics. 11 (1): 519. doi:10.1186/1471-2164-11-519. PMC 2997012  . PMID 20875111.
Jump up ^ Huff, Jason T.; Zilberman, Daniel (2014). "Dnmt1-Independent CG Methylation Contributes to Nucleosome Positioning in Diverse Eukaryotes". Cell. 156 (6): 1286–1297. doi:10.1016/j.cell.2014.01.029. PMC 3969382  . PMID 24630728.
Jump up ^ Yoder, Jeffrey A.; Walsh, Colum P.; Bestor, Timothy H. (1997). "Cytosine methylation and the ecology of intragenomic parasites". Trends in Genetics. 13 (8): 335–340. doi:10.1016/s0168-9525(97)01181-5.
Jump up ^ Lev Maor, Galit; Yearim, Ahuvi; Ast, Gil (2015). "The alternative role of DNA methylation in splicing regulation". Trends in Genetics. 31 (5): 274–280. doi:10.1016/j.tig.2015.03.002.
Jump up ^ Maunakea, Alika K.; Nagarajan, Raman P.; Bilenky, Mikhail; Ballinger, Tracy J.; D’Souza, Cletus; Fouse, Shaun D.; Johnson, Brett E.; Hong, Chibo; Nielsen, Cydney (2010). "Conserved role of intragenic DNA methylation in regulating alternative promoters". Nature. 466 (7303): 253–257. doi:10.1038/nature09165. PMC 3998662  . PMID 20613842.
Jump up ^ Carrozza, Michael J.; Li, Bing; Florens, Laurence; Suganuma, Tamaki; Swanson, Selene K.; Lee, Kenneth K.; Shia, Wei-Jong; Anderson, Scott; Yates, John (November 2005). "Histone H3 Methylation by Set2 Directs Deacetylation of Coding Regions by Rpd3S to Suppress Spurious Intragenic Transcription". Cell. 123 (4): 581–592. doi:10.1016/j.cell.2005.10.023. PMID 16286007.
Jump up ^ Howard Cedar and Yehudit Bergman (July 2012). "Programming of DNA Methylation Patterns". Annual Review of Biochemistry. 81: 97–117. doi:10.1146/annurev-biochem-052610-091920. PMID 22404632. CS1 maint: Uses authors parameter (link) – via Annual Reviews (subscription required)
Jump up ^ Beard, C.; Li, E.; Jaenisch, R. (1995-10-01). "Loss of methylation activates Xist in somatic but not in embryonic cells". Genes & Development. 9 (19): 2325–2334. doi:10.1101/gad.9.19.2325. ISSN 0890-9369. PMID 7557385.
Jump up ^ Li, En; Beard, Caroline; Jaenisch, Rudolf (1993-12-25). "Role for DNA methylation in genomic imprinting". Nature. 366 (6453): 362–365. doi:10.1038/366362a0. PMID 8247133.
Jump up ^ Borgel, Julie; Guibert, Sylvain; Li, Yufeng; Chiba, Hatsune; Schübeler, Dirk; Sasaki, Hiroyuki; Forné, Thierry; Weber, Michael (2010). "Targets and dynamics of promoter DNA methylation during early mouse development". Nature Genetics. 42 (12): 1093–1100. doi:10.1038/ng.708.
Jump up ^ Seisenberger, Stefanie; Peat, Julian R.; Hore, Timothy A.; Santos, Fátima; Dean, Wendy; Reik, Wolf (2013-01-05). "Reprogramming DNA methylation in the mammalian life cycle: building and breaking epigenetic barriers". Philosophical Transactions of the Royal Society B: Biological Sciences. 368 (1609): 20110330. doi:10.1098/rstb.2011.0330. ISSN 0962-8436. PMC 3539359  . PMID 23166394.
Jump up ^ Wang YP, Lei QY. "Metabolic recoding of epigenetics in cancer". Cancer Commun (Lond). 38 (1): 25. doi:10.1186/s40880-018-0302-3. PMID 29784032.
Jump up ^ Daura-Oller E, Cabre M, Montero MA, Paternain JL, Romeu A (2009). "Specific gene hypomethylation and cancer: New insights into coding region feature trends". Bioinformation. 3 (8): 340–343. doi:10.6026/97320630003340. PMC 2720671  . PMID 19707296.
Jump up ^ Craig, JM; Wong, NC (editor) (2011). Epigenetics: A Reference Manual. Caister Academic Press. ISBN 978-1-904455-88-2. CS1 maint: Multiple names: authors list (link) CS1 maint: Extra text: authors list (link)
^ Jump up to: a b c Gonzalo, S (2010). "Epigenetic alterations in aging". Journal of Applied Physiology. 109 (2): 586–597. doi:10.1152/japplphysiol.00238.2010. PMC 2928596  . PMID 20448029.
Jump up ^ Lund, G.L.; Andersson, L.; Lauria, M.; Lindholm, M.; Fraga, M.F.; Villar-Garea, A.; Ballestar, E.; Esteller, M.; Zaina, S. (2004). "DNA methylation polymorphisms precede any histological sign of atherosclerosis in mice lacking Apolipoprotein E". J Biol Chem. 279 (28): 29147–29154. doi:10.1074/jbc.m403618200. PMID 15131116.
Jump up ^ Castro, R.; Rivera, I.; Struys, E.A.; Jansen, E.E.; Ravasco, P.; Camilo, M.E.; Blom, H.J.; Jakobs, C.; Tavares; de Almeida, T. (2003). "Increased homocysteine concentrations and S-adenosylhomocysteine concentrations and DNA hypomethylation in vascular disease". Clin Chem. 49 (8): 1292–1296. doi:10.1373/49.8.1292.
Jump up ^ Huang, Y.S.; Zhi, Y.F.; Wang, S.R. (2009). "Hypermethylation of estrogen receptor-α gene in atheromatosis patients and its correlation with homocysteine". Pathophysiology. 16 (4): 259–265. doi:10.1016/j.pathophys.2009.02.010.
Jump up ^ Dong, C.D.; Yoon, W.; Goldschmidt-Clermont, P.J. (2002). "DNA methylation and atherosclerosis". J Nutr. 132 (8): 2406S–2409S.
Jump up ^ Ying, A.K.; Hassanain, H.H.; Roos, C.M.; Smiraglia, D.J.; Issa, J.J.; Michler, R.E.; Caligiuri, M.; Plass, C.; Goldschmidt-Clermont, P.J. (2000). "Methylation of the estrogen receptor- α gene promoter is selectively increased in proliferating human aortic smooth muscle cells". Cardiovas Res. 46 (1): 172–179. doi:10.1016/s0008-6363(00)00004-3.
Jump up ^ Zhu, S.; Goldschmidt-Clermont, P.J.; Dong, C. (2005). "Inactivation of Monocarboxylate Transporter MCT3 by DNA methylation in atherosclerosis". Circulation. 112 (9): 1353–1361. doi:10.1161/circulationaha.104.519025. PMID 16116050.
Jump up ^ Horvath S (2013). "DNA methylation age of human tissues and cell types". Genome Biology. 14 (R115): R115. doi:10.1186/gb-2013-14-10-r115. PMC 4015143  . PMID 24138928.
Jump up ^ Wong CC1, Caspi A, Williams B, Craig IW, Houts R, Ambler A, Moffitt TE, Mill J (2010). "A longitudinal study of epigenetic variation in twins". Epigenetics. 5 (6): 516–526. doi:10.4161/epi.5.6.12226. PMC 3322496  . PMID 20505345. CS1 maint: Multiple names: authors list (link)
Jump up ^ Heyn, Holger; Li, Ning; Ferreira, Humberto J.; Moran, Sebastian; Pisano, David G.; Gomez, Antonio; Diez, Javier; Sanchez-Mut, Jose V.; Setien, Fernando (2012-06-26). "Distinct DNA methylomes of newborns and centenarians". Proceedings of the National Academy of Sciences. 109 (26): 10522–10527. doi:10.1073/pnas.1120658109. ISSN 0027-8424. PMC 3387108  . PMID 22689993.
^ Jump up to: a b Barrès R1, Yan J, Egan B, Treebak JT, Rasmussen M, Fritz T, Caidahl K, Krook A, O'Gorman DJ, Zierath JR (2012). "Acute exercise remodels promoter methylation in human skeletal muscle". Cell Metabolism. 15 (3): 405–411. doi:10.1016/j.cmet.2012.01.001. PMID 22405075. CS1 maint: Multiple names: authors list (link)
Jump up ^ Rönn T1, Volkov P, Davegårdh C, Dayeh T, Hall E, Olsson AH, Nilsson E, Tornberg A, Dekker Nitert M, Eriksson KF, Jones HA, Groop L, Ling C (2013). "A six months exercise intervention influences the genome-wide DNA methylation pattern in human adipose tissue". PLOS Genetics. 9 (6): e1003572. doi:10.1371/journal.pgen.1003572. PMC 3694844  . PMID 23825961. CS1 maint: Multiple names: authors list (link)
Jump up ^ Zhang FF1, Cardarelli R, Carroll J, Zhang S, Fulda KG, Gonzalez K, Vishwanatha JK, Morabia A, Santella RM (2011). "Physical activity and global genomic DNA methylation in a cancer-free population". Epigenetics. 6 (3): 293–299. doi:10.4161/epi.6.3.14378. PMC 3092677  . PMID 21178401. CS1 maint: Multiple names: authors list (link)
Jump up ^ Miller C, Sweatt J (2007-03-15). "Covalent modification of DNA regulates memory formation". Neuron. 53 (6): 857–869. doi:10.1016/j.neuron.2007.02.022. PMID 17359920.
Jump up ^ Powell, Devin (2008-12-02). "Memories may be stored on your DNA". New Scientist. Retrieved 2008-12-02.
Jump up ^ Gratchev, Alexei. Review on DNA Methylation. (n.d.) Retrieved from http://www.methods.info/Methods/DNA_methylation/Methylation_review.html
Jump up ^ Goll MG, Kirpekar F, Maggert KA, Yoder JA, Hsieh CL, Zhang X, Golic KG, Jacobsen SE, Bestor TH (January 2006). "Methylation of tRNAAsp by the DNA methyltransferase homolog Dnmt2". Science. 311 (5759): 395–398. doi:10.1126/science.1120976. PMID 16424344.
Jump up ^ Cao X, Jacobsen SE (December 2002). "Locus-specific control of asymmetric and CpNpG methylation by the DRM and CMT3 methyltransferase genes". PNAS. 99 (Suppl 4): 16491–16498. doi:10.1073/pnas.162371599. PMC 139913  . PMID 12151602.
^ Jump up to: a b Aufsatz W, Mette MF, van der Winden J, Matzke AJ, Matzke M (2002). "RNA-directed DNA methylation in Arabidopsis". PNAS. 99 (90004): 16499–16506. doi:10.1073/pnas.162371499. PMC 139914  . PMID 12169664.
Jump up ^ Wang, Y; Jorda, M; Jones, PL; et al. (October 2006). "Functional CpG Methylation System in a Social Insect". Science. 314 (5799): 645–647. doi:10.1126/science.1135213. PMID 17068262. CS1 maint: Explicit use of et al. (link)
Jump up ^ Ying and Li-Byarlay (2015). "Physiological and Molecular Mechanisms of Nutrition in Honey Bees". Advances in Insect Physiology. Advances in Insect Physiology. 49: 25–58. doi:10.1016/bs.aiip.2015.06.002. ISBN 9780128025864.
Jump up ^ Li-Byarlay H.; et al. (2013). "RNA interference knockdown of DNA methyl-transferase 3 affects gene alternative splicing in the honey bee". PNAS. 110 (31): 12750–12755. doi:10.1073/pnas.1310735110. PMC 3732956  . PMID 23852726.
Jump up ^ Smith SS, Thomas CA (1981). "The two-dimensional restriction analysis of Drosphila DNAs: males and females". Gene. 13 (4): 395–408. doi:10.1016/0378-1119(81)90019-6. PMID 6266924.
Jump up ^ Lyko, F, Ramsahoye, BH, Jaenisch, J (2000). "DNA methylation in Drosphila". Nature. 408 (6812): 538–540. doi:10.1038/35046205. PMID 11117732.
Jump up ^ Takayama, S.; Dhahbi, J.; Roberts, A.; Mao, G.; Heo, S.-J.; Pachter, L.; Martin, D. I. K.; Boffelli, D. (2014). "Genome methylation in D. melanogaster is found at specific short motifs and is independent of DNMT2 activity". Genome Research. 24 (5): 821–830. doi:10.1101/gr.162412.113. PMC 4009611  . PMID 24558263.
Jump up ^ Zhang, G; Huang, H; Liu, D; Cheng, Y; Liu, X; Zhang, W; Yin, R; Zhang, D; Zhang, P; Liu, J; Li, C; Liu, B; Luo, Y; Zhu, Y; Zhang, N; He, S; He, C; Wang, H; Chen, D (2015). "N6-Methyladenine DNA Modification in Drosophila". Cell. 161 (4): 893–906. doi:10.1016/j.cell.2015.04.018. PMID 25936838.
Jump up ^ Antequera F, Tamame M, Villanueva JR, Santos T (July 1984). "DNA methylation in the fungi". J. Biol. Chem. 259 (13): 8033–8036. PMID 6330093.
Jump up ^ Binz T, D'Mello N, Horgen PA (1998). "A comparison of DNA methylation levels in selected isolates of higher fungi". Mycologia. Mycological Society of America. 90 (5): 785–790. doi:10.2307/3761319. JSTOR 3761319.
Jump up ^ Si-Yang, Liu; Jian-Qing, Lin; Hong-Long, Wu; Cheng-Cheng, Wang; Shu-Jia, Huang; Yan-Feng, Luo; Ji-Hua, Sun; Jian-Xiang, Zhou; Shu-Jing, Yan; Jian-Guo, He; Jun, Wang; Zhu-Mei, He (2012). "Bisulfite sequencing reveals that aspergillus flavus holds a hollow in DNA methylation". PLOS One. 7 (1): e30349. doi:10.1371/journal.pone.0030349. PMC 3262820  . PMID 22276181.
Jump up ^ Selker EU, Tountas NA, Cross SH, Margolin BS, Murphy JG, Bird AP, Freitag M (2003). "The methylated component of the Neurospora crassa genome". Nature. 422 (6934): 893–897. doi:10.1038/nature01564. PMID 12712205.
Jump up ^ Smith SS, Ratner, DI (1991). "Lack of 5-methylcytosine in Dictyostelium discodium DNA". Biochemical Journal. 277(Pt1): 273–275. PMC 1151219  . PMID 1713034.
Jump up ^ Reily, JG, Braun, R, Thomas, CA (1980). "Methylation in Physarum DNA". FEBS Letters. 116 (2): 181–184. doi:10.1016/0014-5793(80)80638-7. PMID 6250882.
Jump up ^ Palmer BR, Marinus MG (1994). "The dam and dcm strains of Escherichia coli—a review". Gene. 143 (1): 1–12. doi:10.1016/0378-1119(94)90597-5. PMID 8200522.
Jump up ^ "Making unmethylated (dam-/dcm-) DNA". Archived from the original on 2011-01-06.
Jump up ^ https://ejfs.springeropen.com/articles/10.1186/s41935-018-0042-1
Jump up ^ Hernández, H. G.; Tse, M. Y.; Pang, S. C.; Arboleda, H.; Forero, D. A. (2013). "Optimizing methodologies for PCR-based DNA methylation analysis". BioTechniques. 55 (4): 181–197. doi:10.2144/000114087. PMID 24107250.
Jump up ^ Wood RJ, Maynard-Smith MD, Robinson VL, Oyston PC, Titball RW, Roach PL (2007). Fugmann, Sebastian, ed. "Kinetic analysis of Yersinia pestis DNA adenine methyltransferase activity using a hemimethylated molecular break light oligonucleotide". PLOS One. 2 (8): e801. doi:10.1371/journal.pone.0000801. PMC 1949145  . PMID 17726531. CS1 maint: Multiple names: authors list (link)
Jump up ^ Li J, Yan H, Wang K, Tan W, Zhou X (February 2007). "Hairpin fluorescence DNA probe for real-time monitoring of DNA methylation". Anal. Chem. 79 (3): 1050–1056. doi:10.1021/ac061694i. PMID 17263334.
Jump up ^ David R. McCarthy, Philip D. Cotter, and Michelle M. Hanna (2012). MethylMeter(r): A Quantitative, Sensitive, and Bisulfite-Free Method for Analysis of DNA Methylation, DNA Methylation – From Genomics to Technology, Dr. Tatiana Tatarinova (Ed.), ISBN 978-953-51-0320-2, InTech, doi:10.5772/36090
Jump up ^ Wojdacz, TK; Dobrovic, A (2007). "Methylation-sensitive high resolution melting (MS-HRM): a new approach for sensitive and high-throughput assessment of methylation". Nucleic Acids Res. 35 (6): e41. doi:10.1093/nar/gkm013. PMC 1874596  . PMID 17289753.
Jump up ^ Malentacchi, F; Forni, G; Vinci, S; Orlando, C (2009). "Quantitative evaluation of DNA methylation by optimization of a differential-high resolution melt analysis protocol". Nucleic Acids Res. 37 (12): e86. doi:10.1093/nar/gkp383. PMC 2709587  . PMID 19454604.
Jump up ^ Gokhman D1, Lavi E, Prüfer K, Fraga MF, Riancho JA, Kelso J, Pääbo S, Meshorer E, Carmel L. (2014). "Reconstructing the DNA methylation maps of the Neandertal and the Denisovan". Science. 344 (6183): 523–7. doi:10.1126/science.1250368. PMID 24786081. CS1 maint: Multiple names: authors list (link)
Jump up ^ Rakyan, VK; Down, TA; Thorne, NP; Flicek, P; Kulesha, E; Gräf, S; Tomazou, EM; Bäckdahl, L; Johnson, N; Herberth, M; Howe, KL; Jackson, DK; Miretti, MM; Fiegler, H; Marioni, JC; Birney, E; Hubbard, TJ; Carter, NP; Tavaré, S; Beck, S (September 2008). "An integrated resource for genome-wide identification and analysis of human tissue-specific differentially methylated regions (tDMRs)". Genome Research. 18 (9): 1518–29. doi:10.1101/gr.077479.108. PMC 2527707  . PMID 18577705.
Jump up ^ Lee, Hwan Young; Park, Myung Jin; Choi, Ajin; An, Ja Hyun; Yang, Woo Ick; Shin, Kyoung-Jin (2011). "Potential forensic application of DNA methylation profiling to body fluid identification". International Journal of Legal Medicine. 126 (1): 55–62. doi:10.1007/s00414-011-0569-2. PMID 21626087.
Jump up ^ Irizarry, RA; Ladd-Acosta, C; Wen, B; Wu, Z; Montano, C; Onyango, P; Cui, H; Gabo, K; Rongione, M; Webster, M; Ji, H; Potash, JB; Sabunciyan, S; Feinberg, AP (February 2009). "The human colon cancer methylome shows similar hypo- and hypermethylation at conserved tissue-specific CpG island shores". Nature Genetics. 41 (2): 178–86. doi:10.1038/ng.298. PMC 2729128  . PMID 19151715.
Jump up ^ Reik, W; Dean, W; Walter, J (Aug 10, 2001). "Epigenetic reprogramming in mammalian development". Science. 293 (5532): 1089–93. doi:10.1126/science.1063443. PMID 11498579.
Jump up ^ Meissner, A; Mikkelsen, TS; Gu, H; Wernig, M; Hanna, J; Sivachenko, A; Zhang, X; Bernstein, BE; Nusbaum, C; Jaffe, DB; Gnirke, A; Jaenisch, R; Lander, ES (Aug 7, 2008). "Genome-scale DNA methylation maps of pluripotent and differentiated cells". Nature. 454 (7205): 766–70. doi:10.1038/nature07107. PMC 2896277  . PMID 18600261.
Jump up ^ Doi, A; Park, IH; Wen, B; Murakami, P; Aryee, MJ; Irizarry, R; Herb, B; Ladd-Acosta, C; Rho, J; Loewer, S; Miller, J; Schlaeger, T; Daley, GQ; Feinberg, AP (December 2009). "Differential methylation of tissue- and cancer-specific CpG island shores distinguishes human induced pluripotent stem cells, embryonic stem cells and fibroblasts". Nature Genetics. 41 (12): 1350–3. doi:10.1038/ng.471. PMC 2958040  . PMID 19881528.
Jump up ^ Bjornsson, HT; Sigurdsson, MI; Fallin, MD; Irizarry, RA; Aspelund, T; Cui, H; Yu, W; Rongione, MA; Ekström, TJ; Harris, TB; Launer, LJ; Eiriksdottir, G; Leppert, MF; Sapienza, C; Gudnason, V; Feinberg, AP (Jun 25, 2008). "Intra-individual change over time in DNA methylation with familial clustering". JAMA: the Journal of the American Medical Association. 299 (24): 2877–83. doi:10.1001/jama.299.24.2877. PMC 2581898  . PMID 18577732.
Jump up ^ Bock, C; Walter, J; Paulsen, M; Lengauer, T (June 2008). "Inter-individual variation of DNA methylation and its implications for large-scale epigenome mapping". Nucleic Acids Research. 36 (10): e55. doi:10.1093/nar/gkn122. PMC 2425484  . PMID 18413340.
Jump up ^ Zhang, Y; Liu, H; Lv, J; Xiao, X; Zhu, J; Liu, X; Su, J; Li, X; Wu, Q; Wang, F; Cui, Y (May 2011). "QDMR: a quantitative method for identification of differentially methylated regions by entropy". Nucleic Acids Research. 39 (9): e58. doi:10.1093/nar/gkr053. PMC 3089487  . PMID 21306990.
Jump up ^ Geeleher P, Hartnett L, Egan LJ, Golden A, Raja Ali RA, Seoighe C (June 2013). "Gene-Set Analysis is Severely Biased When Applied to Genome-wide Methylation Data". Bioinformatics. 29 (15): 1851–7. doi:10.1093/bioinformatics/btt311. PMID 23732277.
Jump up ^ Liu, Hongbo; Liu, Xiaojuan; Zhang, Shumei; Lv, Jie; Li, Song; Shang, Shipeng; Jia, Shanshan; Wei, Yanjun; Wang, Fang; Su, Jianzhong; Wu, Qiong; Zhang, Yan (8 January 2016). "Systematic identification and annotation of human methylation marks based on bisulfite sequencing methylomes reveals distinct roles of cell type-specific hypomethylation in the regulation of cell identity genes". Nucleic Acids Research. 44 (1): 75–94. doi:10.1093/nar/gkv1332. PMC 4705665  . PMID 26635396.
Jump up ^ Bhasin M, Zhang H, Reinherz EL, Reche PA (Aug 2005). "Prediction of methylated CpGs in DNA sequences using a support vector machine". FEBS Lett. 579 (20): 4302–8. doi:10.1016/j.febslet.2005.07.002. PMID 16051225.
Jump up ^ Bock C, Paulsen M, Tierling S, Mikeska T, Lengauer T, Walter J (Mar 2006). "CpG island methylation in human lymphocytes is highly correlated with DNA sequence, repeats, and predicted DNA structure". PLoS Genet. 2 (3): e26. doi:10.1371/journal.pgen.0020026. PMC 1386721  . PMID 16520826.
Jump up ^ Zheng H, Jiang SW, Wu H (2011). "Enhancement on the predictive power of the prediction model for human genomic DNA methylation". International Conference on Bioinformatics and Computational Biology (BIOCOMP'11).
Jump up ^ Zheng H, Jiang SW, Li J, Wu H (2013). "CpGIMethPred: computational model for predicting methylation status of CpG islands in human genome". BMC Medical Genomics.
Further reading[edit]
Law J, Jacobsen SE (2010). "Establishing, maintaining and modifying DNA methylation patterns in plants and animals". Nat. Rev. Genet. 11 (3): 204–220. doi:10.1038/nrg2719. PMC 3034103  . PMID 20142834.
Straussman R, Nejman D, Roberts D, et al. (2009). "Developmental programming of CpG island methylation profiles in the human genome". Nat. Struct. Mol. Biol. 16 (5): 564–571. doi:10.1038/nsmb.1594. PMID 19377480.
Patra SK (2008). "Ras regulation of DNA-methylation and cancer". Exp Cell Res. 314 (6): 1193–1201. doi:10.1016/j.yexcr.2008.01.012. PMID 18282569.
Patra SK, Patra A, Ghosh TC, et al. (2008). "Demethylation of (cytosine-5-C-methyl) DNA and regulation of transcription in the epigenetic pathways of cancer development". Cancer Metast. Rev. 27 (2): 315–334. doi:10.1007/s10555-008-9118-y. PMID 18246412.
External links[edit]
Wikimedia Commons has media related to DNA methylation.
DNA+Methylation at the US National Library of Medicine Medical Subject Headings (MeSH)
ENCODE threads explorer Non-coding RNA characterization. Nature (journal)
PCMdb Pancreatic Cancer Methylation Database.
Nagpal, Gandharva; Sharma, Minakshi; Kumar, Shailesh; Chaudhary, Kumardeep; Gupta, Sudheer; Gautam, Ankur; Raghava, Gajendra P. S. (2014). "PCMdb: Pancreatic Cancer Methylation Database". Scientific Reports. 4. doi:10.1038/srep04197.
SMART Specific Methylation Analysis and Report Tool
Human Methylation Mark Atlas
DiseaseMeth Human disease methylation database
show
v
t
e
Gene expression
Introduction
to genetics
Genetic code
Central dogma
DNA → RNA → Protein
Special transfers
RNA→RNA
RNA→DNA
Protein→Protein
Transcription
Types
Bacterial
Eukaryotic
Key elements
Transcription factor
RNA polymerase
Promoter
Post-transcription
Precursor mRNA (pre-mRNA / hnRNA)
5' capping
Splicing
Polyadenylation
Histone acetylation and deacetylation
Translation
Types
Prokaryotic
Eukaryotic
Key elements
Ribosome
Transfer RNA (tRNA)
Ribosome-nascent chain complex (RNC)
Post-translational modification (functional groups · peptides · structural changes)
Regulation
Epigenetic
imprinting
Transcriptional
Gene regulatory network
cis-regulatory element
lac operon
Post-transcriptional
sequestration (P-bodies)
alternative splicing
microRNA
Translational
Post-translational
reversible
irreversible
Influential people
François Jacob
Jacques Monod
show
v
t
e
Transcription (Bacterial, Eukaryotic)
Transcriptional regulation
prokaryotic
Operon
lac operon
trp operon
gab operon
ara operon
gal operon
Repressor
lac repressor
trp repressor
eukaryotic
Histone-modifying enzymes
(histone/nucleosome):
Histone methylation/Histone methyltransferase
EZH2
Histone demethylase
Histone acetylation and deacetylation
Histone deacetylase HDAC1
Histone acetyltransferase
DNA methylation:
DNA methyltransferase
Chromatin remodeling:
CHD7
both
Transcription coregulator
Coactivator
Corepressor
Inducer
Promotion
Promoter
Pribnow box
TATA box
BRE
CAAT box
Response element
Enhancer
E-box
Response element
Insulator
Silencer
Internal control region
Initiation
Bacterial
Eukaryotic
Archaeal transcription factor B
Elongation
bacterial RNA polymerase: rpoB
eukaryotic RNA polymerase: RNA polymerase II
Termination
(bacterial,
eukaryotic)
Terminator
Intrinsic termination
Rho factor
Retrieved from "https://en.wikipedia.org/w/index.php?title=DNA_methylation&oldid=850938531"
Categories:
DNA
Epigenetics
Hidden categories:
CS1 maint: Uses authors parameter
Subscription required using via
Pages containing links to subscription-only content
CS1 maint: Multiple names: authors list
CS1 maint: Extra text: authors list
CS1 maint: Explicit use of et al.
All articles with unsourced statements
Articles with unsourced statements from November 2010
Articles with specifically marked weasel-worded phrases from December 2010
Navigation menu
Personal tools
Not logged in
Talk
Contributions
Create account
Log in
Namespaces
Article
Talk
Variants
Views
Read
Edit
View history
More
Search
Navigation
Main page
Contents
Featured content
Current events
Random article
Donate to Wikipedia
Wikipedia store
Interaction
Help
About Wikipedia
Community portal
Recent changes
Contact page
Tools
What links here
Related changes
Upload file
Special pages
Permanent link
Page information
Wikidata item
Cite this page
Print/export
Create a book
Download as PDF
Printable version
In other projects
Wikimedia Commons
Languages
العربية
Català
Čeština
Deutsch
Eesti
Español
فارسی
Français
Galego
한국어
Bahasa Indonesia
Italiano
ქართული
Nederlands
日本語
Polski
Português
Русский
Simple English
Svenska
Türkçe
Українська
اردو
中文
15 more
Edit links
This page was last edited on 19 July 2018, at 00:00 (UTC).
Text is available under the Creative Commons Attribution-ShareAlike License; additional terms may apply. By using this site, you agree to the Terms of Use and Privacy Policy. Wikipedia® is a registered trademark of the Wikimedia Foundation, Inc., a non-profit organization.
Privacy policy
About Wikipedia
Disclaimers
Contact Wikipedia
Developers
Cookie statement
Mobile view
Enable previews

key: html

type: local

value: div

attrs: id class

values: mw-page-base noprint

values: mw-head-base noprint

value: a

attrs: id class lang

values: firstHeading firstHeading en

values: siteSub noprint

attrs: class href

values: mw-jump-link #mw-head

values: mw-jump-link #p-search

value: img

attrs: alt src width height class srcset data-file-width data-file-height

attrs: href class

attrs: href class title

attrs: class style

attrs: href title

values:
/wiki/Transcription_(genetics)
mw-redirect
Transcription (genetics)

values:
/wiki/X-chromosome_inactivation
mw-redirect
X-chromosome inactivation

values:
/wiki/Mus_musculus
mw-redirect
Mus musculus

values:
/wiki/Uracil_in_DNA
mw-redirect
Uracil in DNA

values:
/wiki/Neural_development
mw-redirect
Neural development

values: checkbox button toctogglecheckbox toctogglecheckbox display:none

values: Edit section: Conserved function of DNA methylation

values:
/wiki/Histone_modification
mw-redirect
Histone modification

values: Edit section: Repression of CpG-dense promoters

values:
/wiki/Methyl_CpG_binding_protein_2
mw-redirect
Methyl CpG binding protein 2

values: Edit section: Repression of transposable elements

values: Edit section: Methylation of the gene body of highly transcribed genes

values: Edit section: During embryonic development

values:
/wiki/DNA_methylation_reprogramming
mw-redirect
DNA methylation reprogramming

values:
/wiki/Differentiated_cell
mw-redirect
Differentiated cell

values:
/wiki/Transcriptional_silencing
mw-redirect
Transcriptional silencing

values:
/wiki/Tumor_suppressor_gene
mw-redirect
Tumor suppressor gene

values: Peroxisome proliferator-activated receptor gamma

values: Edit section: DNA methyltransferases (in mammals)

values:
/wiki/Base_analog
mw-redirect
Base analog

values:
nofollow
http://chromdb.org/
external text

values:
/wiki/RNA_viruses
mw-redirect
RNA viruses

values: This claim needs references to reliable sources. (November 2010)

values:
noprint Inline-Template Template-Fact
white-space:nowrap;

values:
/wiki/Dna_adenine_methylase
mw-redirect
Dna adenine methylase

values: The material near this tag may use weasel words or too-vague attribution. (December 2010)

values: Wikipedia:Manual of Style/Words to watch

values:
/wiki/DNA_microarrays
mw-redirect
DNA microarrays

values: Edit section: Differentially methylated regions (DMRs)

values:
nofollow
external free
http://bioinfo.hrbmu.edu.cn/qdmr

values: DNA methylation marks (page does not exist)

values:
nofollow
http://fame.edbc.org/smart/
external free

values:
/wiki/Biological_clock_(aging)
mw-redirect
Biological clock (aging)

values:
/wiki/PubMed_Identifier
mw-redirect
PubMed Identifier

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/5530731

values:
nofollow
external text
//doi.org/10.1101/166033

values:
nofollow
external text
//doi.org/10.1042/bj20140844

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/25299492

values:
nofollow
external text
//doi.org/10.1126/science.1186366

values:
nofollow
external text
//www.worldcat.org/issn/0036-8075

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/20395474

values:
nofollow
external text
//doi.org/10.1021/ac500447w

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/24640988

values:
nofollow
external text
//doi.org/10.1002/bies.20342

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/16479578

values:
nofollow
external text
//doi.org/10.1038/nature17640

values:
nofollow
external text
//www.worldcat.org/issn/0028-0836

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/27027282

values:
nofollow
external text
//doi.org/10.3389/fgene.2016.00099

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/27375676

values: Category:CS1 maint: Uses authors parameter

values:
nofollow
external text
//doi.org/10.1006/dbio.2001.0504

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/11784085

values:
nofollow
external text
//doi.org/10.1038/nature08514

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/19829295

values:
nofollow
external text
//doi.org/10.1126/science.1237905

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/23828890

values:
nofollow
external text
//doi.org/10.1038/ng.3291

values:
nofollow
external text
//www.worldcat.org/issn/1061-4036

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/26053498

values:
nofollow
external text
//doi.org/10.1093/nar/10.8.2709

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/7079182

values:
nofollow
external text
//doi.org/10.1038/nature11086

values:
nofollow
external text
//doi.org/10.1101/gr.6163007

values:
nofollow
external text
//www.worldcat.org/issn/1088-9051

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/17420183

values:
nofollow
external text
//doi.org/10.1038/35057062

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/11237011

values:
nofollow
external text
//doi.org/10.1038/321209a0

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/2423876

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/3656447

values:
nofollow
external text
//doi.org/10.1371/journal.pgen.1001134

values:
nofollow
external text
//www.worldcat.org/issn/1553-7404

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/20885785

values:
nofollow
external text
http://www.pnas.org/content/103/5/1412

values:
nofollow
external text
//doi.org/10.1073/pnas.0510310103

values:
nofollow
external text
//www.worldcat.org/issn/0027-8424

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/16432200

values:
nofollow
external text
http://www.pnas.org/content/107/19/8689

values:
nofollow
external text
//doi.org/10.1073/pnas.1002720107

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/20395551

values:
nofollow
external text
//doi.org/10.1016/j.molcel.2008.05.007

values:
nofollow
external text
//doi.org/10.1038/ng1990

values:
nofollow
external text
//doi.org/10.1038/nature14192

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/20875111

values:
nofollow
external text
//doi.org/10.1016/j.cell.2014.01.029

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/24630728

values:
nofollow
external text
//doi.org/10.1016/j.tig.2015.03.002

values:
nofollow
external text
//doi.org/10.1038/nature09165

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/20613842

values:
nofollow
external text
//doi.org/10.1016/j.cell.2005.10.023

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/16286007

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/22404632

values:
nofollow
external text
//doi.org/10.1101/gad.9.19.2325

values:
nofollow
external text
//www.worldcat.org/issn/0890-9369

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/7557385

values:
nofollow
external text
//doi.org/10.1038/366362a0

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/8247133

values:
nofollow
external text
//doi.org/10.1038/ng.708

values:
nofollow
external text
//doi.org/10.1098/rstb.2011.0330

values:
nofollow
external text
//www.worldcat.org/issn/0962-8436

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/23166394

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/29784032

values:
nofollow
external text
//doi.org/10.6026/97320630003340

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/19707296

values: Category:CS1 maint: Multiple names: authors list

values: Category:CS1 maint: Extra text: authors list

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/20448029

values:
nofollow
external text
//doi.org/10.1074/jbc.m403618200

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/15131116

values:
nofollow
external text
//doi.org/10.1373/49.8.1292

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/16116050

values:
nofollow
external text
//doi.org/10.1186/gb-2013-14-10-r115

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/24138928

values:
nofollow
external text
//doi.org/10.4161/epi.5.6.12226

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/20505345

values:
nofollow
external text
//doi.org/10.1073/pnas.1120658109

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/22689993

values:
nofollow
external text
//doi.org/10.1016/j.cmet.2012.01.001

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/22405075

values:
nofollow
external text
//doi.org/10.1371/journal.pgen.1003572

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/23825961

values:
nofollow
external text
//doi.org/10.4161/epi.6.3.14378

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/21178401

values:
nofollow
external text
//doi.org/10.1016/j.neuron.2007.02.022

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/17359920

values:
nofollow
external text
//doi.org/10.1126/science.1120976

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/16424344

values:
nofollow
external text
//doi.org/10.1073/pnas.162371599

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/12151602

values:
nofollow
external text
//doi.org/10.1073/pnas.162371499

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/12169664

values:
nofollow
external text
//doi.org/10.1126/science.1135213

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/17068262

values: Category:CS1 maint: Explicit use of et al.

values:
nofollow
external text
//doi.org/10.1016/bs.aiip.2015.06.002

values:
nofollow
external text
//doi.org/10.1073/pnas.1310735110

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/23852726

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/6266924

values:
nofollow
external text
//doi.org/10.1038/35046205

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/11117732

values:
nofollow
external text
//doi.org/10.1101/gr.162412.113

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/24558263

values:
nofollow
external text
//doi.org/10.1016/j.cell.2015.04.018

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/25936838

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/6330093

values: Mycologia (journal) (page does not exist)

values:
nofollow
external text
//doi.org/10.2307/3761319

values:
nofollow
external text
//www.jstor.org/stable/3761319

values:
nofollow
external text
//doi.org/10.1371/journal.pone.0030349

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/22276181

values:
nofollow
external text
//doi.org/10.1038/nature01564

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/12712205

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/1713034

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/6250882

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/8200522

values:
nofollow
external text
//doi.org/10.2144/000114087

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/24107250

values:
nofollow
external text
//doi.org/10.1371/journal.pone.0000801

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/17726531

values:
nofollow
external text
//doi.org/10.1021/ac061694i

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/17263334

values:
nofollow
external text
https://doi.org/10.5772%2F36090

values:
nofollow
external text
//doi.org/10.1093/nar/gkm013

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/17289753

values:
nofollow
external text
//doi.org/10.1093/nar/gkp383

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/19454604

values:
nofollow
external text
//doi.org/10.1126/science.1250368

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/24786081

values:
nofollow
external text
//doi.org/10.1101/gr.077479.108

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/18577705

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/21626087

values:
nofollow
external text
//doi.org/10.1038/ng.298

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/19151715

values:
nofollow
external text
//doi.org/10.1126/science.1063443

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/11498579

values:
nofollow
external text
//doi.org/10.1038/nature07107

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/18600261

values:
nofollow
external text
//doi.org/10.1038/ng.471

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/19881528

values:
nofollow
external text
//doi.org/10.1001/jama.299.24.2877

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/18577732

values:
nofollow
external text
//doi.org/10.1093/nar/gkn122

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/18413340

values:
nofollow
external text
//doi.org/10.1093/nar/gkr053

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/21306990

values:
nofollow
external text
//doi.org/10.1093/bioinformatics/btt311

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/23732277

values:
nofollow
external text
//doi.org/10.1093/nar/gkv1332

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/26635396

values:
nofollow
external text
//doi.org/10.1016/j.febslet.2005.07.002

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/16051225

values:
nofollow
external text
//doi.org/10.1371/journal.pgen.0020026

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/16520826

values: -moz-column-width: 30em; -webkit-column-width: 30em; column-width: 30em; list-style-type: decimal;

values:
nofollow
external text
//doi.org/10.1038/nrg2719

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/20142834

values:
nofollow
external text
//doi.org/10.1038/nsmb.1594

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/19377480

values:
nofollow
external text
//doi.org/10.1016/j.yexcr.2008.01.012

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/18282569

values:
nofollow
external text
//doi.org/10.1007/s10555-008-9118-y

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/18246412

values:
nofollow
http://crdd.osdd.net/raghava/pcmdb/
external text

values:
nofollow
external text
//doi.org/10.1038/srep04197

values:
nofollow
http://fame.edbc.org/smart/
external text

values:
/wiki/Reverse_transcription
mw-redirect
Reverse transcription

values:
row
navbox-group
width:8.0em;font-weight: normal;

values:
/wiki/Precursor_mRNA
mw-redirect
Precursor mRNA

values:
/wiki/Posttranslational_modification
mw-redirect
Posttranslational modification

values: nowraplinks collapsible autocollapse navbox-inner mw-collapsible mw-made-collapsible mw-collapsed

values:
/wiki/Silencer_(DNA)
mw-redirect
Silencer (DNA)

values: Category:Subscription required using via

values: Category:Pages containing links to subscription-only content

values: Category:All articles with unsourced statements

values: Category:Articles with unsourced statements from November 2010

values: Category:Articles with specifically marked weasel-worded phrases from December 2010

values: Discussion about edits from this IP address [ctrl-alt-n]

values: A list of edits made from this IP address [ctrl-alt-y]

values: You are encouraged to create an account and log in; however, it is not mandatory

values: You're encouraged to log in; however, it's not mandatory. [ctrl-alt-o]

values:
/wiki/DNA_methylation
View the content page [ctrl-alt-c]
c

values: Discussion about the content page [ctrl-alt-t]

values: p-namespaces navigation vectorTabs p-namespaces-label

values:
p-variants
navigation
vectorMenu emptyPortlet
p-variants-label

values: Past revisions of this page [ctrl-alt-h]

values: p-views navigation vectorTabs p-views-label

values:
p-cactions
navigation
vectorMenu emptyPortlet
p-cactions-label

values:
mw-wiki-logo
/wiki/Main_Page
Visit the main page

values:
/wiki/Main_Page
Visit the main page [ctrl-alt-z]
z

values: Featured content – the best of Wikipedia

values: Find background information on current events

values:
/wiki/Special:Random
Load a random article [ctrl-alt-x]
x

values: portal navigation p-navigation p-navigation-label

values: Guidance on how to use and edit Wikipedia

values: About the project, what you can do, where to find things

values: A list of recent changes in the wiki [ctrl-alt-r]

values: portal navigation p-interaction p-interaction-label

values: List of all English Wikipedia pages containing links to this page [ctrl-alt-j]

values: portal navigation p-wikibase-otherprojects p-wikibase-otherprojects-label

values: مثيلة الحمض النووي الريبوزي المنقوص الأكسجين – Arabic

values:
interlanguage-link interwiki-ca
display: none;

values:
interlanguage-link interwiki-cs
display: none;

values:
interlanguage-link interwiki-et
display: none;

values: دی‌ان‌ای متیلاسیون – Persian

values:
interlanguage-link interwiki-fa
display: none;

values:
interlanguage-link interwiki-gl
display: none;

values:
interlanguage-link interwiki-ko
display: none;

values:
interlanguage-link interwiki-it
display: none;

values: დნმ-ის მეთილირება – Georgian

values:
interlanguage-link interwiki-ka
display: none;

values:
interlanguage-link interwiki-nl
display: none;

values:
interlanguage-link interwiki-ja
display: none;

values:
interlanguage-link interwiki-pl
display: none;

values: Метилирование ДНК – Russian

values:
interlanguage-link interwiki-simple
display: none;

values:
interlanguage-link interwiki-sv
display: none;

values:
interlanguage-link interwiki-tr
display: none;

values: Метилювання ДНК – Ukrainian

values:
interlanguage-link interwiki-uk
display: none;

values: ڈی این اے میثائلیت – Urdu

values: All languages (initial selection from common choices by you and others)

values: mediawiki ltr sitedir-ltr mw-hide-empty-elt ns-0 ns-subject page-DNA_methylation rootpage-DNA_methylation skin-vector action-view